/Investor DB

Angelor

Impact investor

Seed–Series A · 6 people tracked

Find your way into Angelor

Sign up to see every warm intro you have to Angelor

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Angelor team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Angelor invests in and supports French healthcare scaleups, backing innovations from spin-off stage through Series A that have demonstrated both medical and economic potential. The firm provides capital along with business and health-sector expertise, acting as a sparring partner to companies and their leaders with the help of an active community of experienced investors and entrepreneurs. Its goal is to accelerate the clinical, industrial and commercial scale-up of innovations that can make a difference to patient health within five years, unifying economic performance with medical progress. As a mission-driven company, Angelor also commits roughly 10% of its carried interest to health-related associations.

Source: firm website, verified Sep 27, 2026.

Stage
Seed–Series A
Instruments
Equity
Last 12 months
1 investment
Tracked investments
2

Team · 6 people

from the firm's website

What they invest in

from 2 of 2 portfolio companies

Climate Tech ×2FoodTech ×2AgTech ×1Biotech ×1Deep Tech ×1New Materials ×1

HQs:France×2

Investments · 2 tracked

founders shown can be your intro path
nextProteinnextprotein.coin𝕏✓ verified

nextProtein breeds Black Soldier Fly larvae on unconsumed food to produce insect-based protein, oil and fertilizer used as ingredients in animal feed for aquaculture, poultry, pork and pet food.

AgTechClimate TechFoodTechParis, FR

Syrine Chaalala(Co-founder)inMohamed Gastli(Co-founder)in

Co-investorsKima VenturesAnaxagoBritish International InvestmentMirovaRAISE

Standing Ovationstanding-ovation.coinMar 2026 · $34.2M

Standing Ovation produces animal-free casein, the main protein in milk, using a patented process that replicates the structure and amino acid sequence of cow, goat, or sheep casein without livestock farming.

BiotechClimate TechDeep TechFoodTechNew Materials

Romain Chayot(Co-founder, Board Member & President)in

Co-investorsAstanor VenturesBig Idea VenturesSeventure PartnersBpifrancePeakBridge VC

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Angelor invest at?
Angelor invests at the Seed, Series A stages.
What sectors does Angelor focus on?
Angelor focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.

Similar investors

Featured in lists